Case File
efta-efta01903820DOJ Data Set 10CorrespondenceEFTA Document EFTA01903820
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01903820
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
From: !e yEpstein
Sent
Thur 2/14/2013 8:28:02 PM
Subject Fwd:
Forwarded message
From:
Date: Thu, Feb 14, 2013 at 3:16 PM
Subject: Re:
To: Jeffrey Epstein <[email protected]>
Jeffrey,
Apologies for my late reply.
I will be able to come on 27th February, basically not possible to make it earlier, but I will stay
until 2-3 March. In any way, it would be a great chance to meet potential private and institutional
investors, US equity managers, etc.
As per your request about my role in BCM, I am responsible for managing communication with
shareholders, analysts, building relationships with existing and potential private and institutional
investors in the fund. I am also participating in the investors roundtable cap-intro events,
presenting the BCM to investors one-on-one. On the daily basis, I am responding to clients'
enquiries concerning performance of the fund and general market conditions.
From the organisational perspective, I am also working on weekly and monthly newsletters of the
fund, presenting quarterly results, and, finally, assisting Dr. Chris in gathering the market data,
etc.
Well, this is what I do.
Looking forward to hearing from you.
Regards,
Vaiva
Sent from my iPhone
On 14 Feb 2013, at 16:54, Jeffrey Epstein <[email protected]> wrote:
99
The information contained in this communication is confidential, may be attorney-client privileged, may
PROT2
PROT0
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacationAgmail.com, and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
PROT3
PROT1
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.